Phase II Study of Intravenous Immunoglobulin (IVIg) for Alzheimer's Disease

NCT00299988 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

24

Enrollment

OTHER

Sponsor class

Conditions

Alzheimer's Disease

Interventions

DRUG: Intravenous Immunoglobulin
OTHER: Placebo

Sponsor

Weill Medical College of Cornell University

Collaborators

[object Object]
[object Object]